UnknownPhase 2NCT05720234

Avatrombopag Combined With IST as First-line Treatment for SAA

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Principal Investigator
Xin Zhao
Institute of Hematology & Blood Diseases Hospital, China
Intervention
avatrombopag(drug)
Enrollment
53 enrolled
Eligibility
12-60 years · All sexes
Timeline
20222024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05720234 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia

← Back to all trials